Malignant Peripheral Nerve Sheath Tumor of the Cervix

被引:9
作者
Zhang, Tiantian [1 ]
Wang, Zishu [1 ]
Wang, Rui [1 ]
Wu, Xiao [1 ]
Zhao, Menglin [1 ]
Su, Fang [1 ]
机构
[1] Bengbu Med Coll, Affiliated Hosp 1, Dept Med Oncol, Bengbu, Anhui, Peoples R China
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2022年 / 32卷
关键词
Malignant peripheral nerve sheath tumor; Cervix; Pulmonary metastasis; Hysterectomy; Chemotherapy; SOFT-TISSUE; DIFFERENTIATION; FEATURES;
D O I
10.29271/jcpsp.2022.JCPSPCR.CR24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The occurrence of primary malignant peripheral neurilemmoma in the female cervix without neurofibromatosis type 1 is extremely rare. We, herein, report a case of a 46-year woman with malignant peripheral nerve sheath tumor (MPNST) involving the cervix. The patient was admitted to the hospital because of irregular vaginal bleeding. Pelvic CT suggested the presence of cervical mass, and the patient accepted radical hysterectomy. Following the surgery, MPNST was diagnosed by a combination of histology and immunohistochemistry. One year later, the patient developed recurrence and pulmonary metastasis and received sequentially epiubicin/ifosfamide, dacarbazine, and etoposide/cisplatin multi-line chemotherapy. The prognosis of MPNST is poor, which is related to its invasiveness, high recurrence and metastasis rates. The patient was treated with surgery, multi-line chemotherapy and targeted therapy, but the overall survival (OS) was 44 months. It is the first reported case of cervical MPNST receiving combined treatment.
引用
收藏
页码:24 / 27
页数:4
相关论文
共 12 条
[1]   RANDOMIZED COMPARISON OF DOXORUBICIN ALONE VERSUS IFOSFAMIDE PLUS DOXORUBICIN OR MITOMYCIN, DOXORUBICIN, AND CISPLATIN AGAINST ADVANCED SOFT-TISSUE SARCOMAS [J].
EDMONSON, JH ;
RYAN, LM ;
BLUM, RH ;
BROOKS, JSJ ;
SHIRAKI, M ;
FRYTAK, S ;
PARKINSON, DR .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1269-1275
[2]   Malignant peripheral nerve sheath tumours in neurofibromatosis 1 [J].
Evans, DGR ;
Baser, ME ;
McGaughran, J ;
Sharif, S ;
Howard, E ;
Moran, A .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) :311-314
[3]   Malignant Peripheral Nerve Sheath Tumors: Differentiation Patterns and Immunohistochemical Features - A Mini-Review and Our New Findings [J].
Guo, Aitao ;
Liu, Aijun ;
Wei, Lixin ;
Song, Xin .
JOURNAL OF CANCER, 2012, 3 :303-309
[4]   Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1 [J].
Hwang, In Kyung ;
Hahn, Seung Min ;
Kim, Hyo Sun ;
Kim, Sang Kyum ;
Kim, Hyo Song ;
Shin, Kyoo-Ho ;
Suh, Chang Ok ;
Lyu, Chuhi Joo ;
Han, Jung Woo .
CANCER RESEARCH AND TREATMENT, 2017, 49 (03) :717-726
[5]   First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study [J].
Kroep, J. R. ;
Ouali, M. ;
Gelderblom, H. ;
Le Cesne, A. ;
Dekker, T. J. A. ;
Van Glabbeke, M. ;
Hogendoorn, P. C. W. ;
Hohenberger, P. .
ANNALS OF ONCOLOGY, 2011, 22 (01) :207-214
[6]   The Role for Radiation Therapy in the Management of Sarcoma [J].
Leachman, Brooke K. ;
Galloway, Thomas J. .
SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (05) :1127-+
[7]   Early Outcomes for Malignant Peripheral Nerve Sheath Tumor Treated With Chemotherapy [J].
Moretti, Vincent M. ;
Crawford, Eileen A. ;
Staddon, Arthur P. ;
Lackman, Richard D. ;
Ogilvie, Christian M. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (04) :417-421
[8]   Malignant Peripheral Nerve Sheath Tumors of the Head and Neck: A Case Series and Literature Review [J].
Mullins, Brandon T. ;
Hackman, Trevor .
CASE REPORTS IN OTOLARYNGOLOGY, 2014, 2014
[9]   Should Patients with High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy? [J].
Schuetze, Scott M. ;
Patel, Shreyaskumar .
ONCOLOGIST, 2009, 14 (10) :1003-1012
[10]  
SORDILLO PP, 1981, CANCER-AM CANCER SOC, V47, P2503, DOI 10.1002/1097-0142(19810515)47:10<2503::AID-CNCR2820471033>3.0.CO